Or Refractory Solid Tumours

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-02-24
Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the safety and tolerability of LiPlaCis in patients with advanced or refractory tumours; trial complete…